Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 19, 2026
The Conestoga Micro Cap Composite delivered strong relative capital preservation during the third quarter of 2026, declining -0.83% net of fees compared to a -12.15% drop for the benchmark Russell Microcap Growth Index, generating over 1,100 basis points of outperformance. Year-to-date through September 30, 2026, the strategy generated a net return of +12.50% net of fees, outpacing the benchmark return of +8.50%. The strategy maintained a concentrated portfolio of quality micro-cap growth equities, ending the period with a cash weighting of 3.4% and total composite assets of $56.2 million across 4 member portfolios within the firm's $3.8 billion institutional asset base. The broader market backdrop was heavily dictated by macroeconomic volatility, characterized by stubborn inflation prints, resilient labor conditions, and a 25 basis point rate hike by the Federal Reserve in September that lifted the federal funds rate to 3.75%-4.00%. Long-duration benchmark assets faced aggressive valuation compression, exacerbated by geopolitical friction in the Middle East that pushed crude oil prices above $100 per barrel. Despite these headwinds, the portfolio benefited from disciplined stock selection across secular growth niches, which shielded capital against factor rotations away from low-quality, unprofitable speculative equities. Relative outperformance was anchored by strong operational gains in Health Care, Technology, and Financials. Core contributors included bioprocessing and synthetic biology providers Twist Bioscience and BioLife Solutions, alongside enterprise software businesses. The strategy actively deployed capital by initiating new positions in Standex International and EZCORP, while exiting Hillman Solutions due to slowing organic growth and rising balance sheet leverage, and harvesting Bowman Consulting Group following an announced take-private acquisition.
Conestoga's investment philosophy focuses on owning high-quality micro-cap companies with durable business models, conservative growth profiles, strong management teams, and the capacity to compound earnings sustainably through full market cycles.
Conestoga believes the market will increasingly reward companies with durable business models, strong management teams, and the ability to grow through a higher-cost operating environment as earnings growth moderates.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Conestoga Micro Cap Composite or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.